Archive for ‘Cardiology’

Page 1 of 1612345...10...Last »

Continuous Glucose Monitoring Systems Market Research, New study, Overview, Medical Devices Pipeline Assessment, 2016

Continuous Glucose Monitoring Systems Market Research, New study, Overview, Medical Devices Pipeline Assessment, 2016

MrrBiz246

 

The report analyzes and presents an overview on “Continuous Glucose Monitoring Systems – Medical Devices Pipeline Assessment, 2016″ worldwide.

Summary

GlobalData’s Medical Devices sector report, Continuous Glucose Monitoring Systems – Medical Devices Pipeline Assessment, 2016″ provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Get The Sample Copy Of This Report:http://www.marketresearchreports.biz/sample/sample/901144

Scope

– Extensive coverage of the Continuous Glucose Monitoring Systems under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Continuous Glucose Monitoring Systems under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the products current stage of development, territory and estimated launch date

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

To View The Latest Industry Press Releases: http://www.marketresearchreports.biz/pressreleases

Contact
Tel: +1-518-621-2074
E-Mail: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/

Full story

LEVL Measures Acetone in Breath to Detect Body Fat Burning

LEVL Measures Acetone in Breath to Detect Body Fat Burning

levl

 

levl-parts

 

Medamonitor, a division of GM Nameplate, a Seattle, WA company, received FDA Class I certification for its LEVL acetone breath testing device. Designed for detecting how well your body burns fat, rather than forindirect blood glucose testing, the device relies on studies showing a correlation between exhaled acetone and burned body fat. This can be an important indicator, as body weight can vary due to changes in water and muscle content, in addition to fat. Those wishing to lose body fat, rather than muscle mass or water, would be able to detect whether their diet and exercise regimen is doing the trick.

The device includes a couple pods into which breaths are deposited and then placed into the main unit’s testing port. The front of the unit will then display a “LEVL score” between 1 and 6, and the reading will also be synced with the accompanied smartphone app. Scores 2 and higher mean an elevated level of acetone, pointing to the body burning fat as expected.

Medamonitor promises to give an update on the price and availability of the LEVL early next year. For now here’s a promo video from the company introducing the LEVL:

Flashback: Portable Acetone Detector to Help Monitor Fat Burning During Exercise…

Product page: LEVL…

Via: Medamonitor…

Full story

IRadimed’s MRI Compatible MRidium 3860+ IV Infusion Pump FDA Cleared

IRadimed’s MRI Compatible MRidium 3860+ IV Infusion Pump FDA Cleared

iradimed-pump

 

IRadimed, a company out of Winter Springs, Florida, won FDA clearance for its MRidium 3860+ MRI-compatible IV infusion pump. The device has non-magnetic motor and no ferrous (containing iron) components that would be affected by a magnetic field. It’s safe to use around MRI machines up to 3.0 Tesla, which means just about any scanner found inside a hospital.

mridiumThe device can pump doses from 0.1 mL to 1,400 mL per hour, and so can be used with pediatric and adult patients that may need very different infusion rates.

Thanks to a built-in lithium battery, the device can be self-powered for up to 12 hours at 125 mL per hour.

  • World’s ‘Only’ Non–Magnetic IV Infusion Pump
  • Placement up to the 10,000 Gauss Line
  • Intuitive Smart IV Pump technology reduces field errors
  • Expandable to a second infusion channel
  • Masimo™ SpO2 Patient Monitoring
  • Large 10-Numeric Keypad – Quick Programming
  • Infusion Range – 0.1 to 1400 mL/Hr
  • Over 12–Hour Battery at 125mL/Hr
  • Adjustable KVO Rate
  • Upstream / Downstream Occlusion Detection
  • Air-in-Line Detection
  • Delivery via Syringe, Bag or Bottle

Product page: MRidium 3860+…

Via: IRadimed…

Full story

Miniature Sensor Measures Velocity of Blood Flow Below Skin

Miniature Sensor Measures Velocity of Blood Flow Below Skin

blood-flow-sensor-full

 

1205_nvid02

 

Kyocera Corporation out of Kyoto, Japan has announced the development of a tiny optical sensor for measuring blood flow within subcutaneous tissue. Readings from such a device may help assess how injured tissue is healing, produce evidence of dehydration, and detect altitude sickness. Many other applications may come to light as this kind of technology becomes widely available for use by the public.

The sensor measures 1.6 mm by 3.2 mm and is only 1 mm in height. Because of its size it can be integrated into various devices, including smartphones and wearable activity trackers. Within the sensor is a laser that shines light onto the skin, and a photodiode that converts light returning from the skin into an electrical signal. By detecting and measuring the Doppler shift of the returning light compared to what the laser emits, the device can extrapolate how fast red blood cells are moving. Moreover, the strength of the light signal bouncing from the skin is indicative of the concentration of red blood cells, another interesting indicator.

The sensor at the moment only works on certain parts of the body where there’s a lot of blood perfusion close to the surface of the skin. This includes the ear lobe, fingers, and the forehead, and may include other parts of the body. It’s probably not very effective for using on the bottom of feet for people at risk of diabetic neuropathy, for example.

 

sensor-diagram

Via: KYOCERA…

Full story

Scientists Have Opened the Door to Biological Pacemaker Therapy

Scientists Have Opened the Door to Biological Pacemaker Therapy

cardiac-pacing-cells

 

Throughout life each heart beat is regulated primarily by a specialized tissue called the sinoatrial node. Unfortunately, this natural pacemaker’s ability to maintain the heart rate properly can be disrupted by a number of issues including congenital defects, aging, or ischemic heart disease. Recent work produced by researchers in Dr. Gordon Keller’s lab at the University of Toronto may lead to new therapies based on natural pacemaker cells grown in the lab. These human pacemaker-like cells had the ability to generate electricity spontaneously and were able to pace a  rat heart after being implanted for 2 weeks.

To create this specialized cell type, they took a developmental biology approach by changing the cell culture conditions with the same small molecules and proteins that developing pacemaker cells encounter in the embryo. After careful tuning, the human stem cells were transformed into an enriched population of the desired human pacemaker cells. This is exciting because other sources of progenitor cells have been genetically-engineered to overexpress a potent cancer gene. The final cells derived in this work are a closer match to “real” pacemaker cells and are safer for clinical use.

After verifying that the cells displayed proper bioelectric behaviors in the Petri dish, the researcher took the project one step further by injecting the cells directly into a rat heart. Implanted pacemaker cells were shown to not only connect with the host cells by sharing hollow proteins that allow ions to flow in and out between the cells to pass electric signals, but the human pacemaker cells were able to pace the rat’s own ventricular cells.

Electronic pacemakers, although they have been unquestionably an essential life-sustaining device for thousands of patients, suffer from a number of drawbacks including: the inability to adapt/grow to changes in the heart (particularity important for pediatric patients), potential risk of infection after implantation, limited battery life, and even failure due to electromagnetic interference.

This work presents the exciting possibility that one day patients in need of pacemaker treatment could receive an injection of lab-grown pacemaker cells that could serve as a life-long cure, avoiding the need to implant an electronic pacemaker. Next steps will likely involve testing in the sinoatrial node of rodents and eventually moving to large animal models such as the pig.

Here’s video of in-vitro demonstration of the stem cell-derived pacemaker heart cells:

Study in Nature Biotechnology: Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker…

Full story

IRadimed’s MRI Compatible MRidium 3860+ IV Infusion Pump FDA Cleared

IRadimed’s MRI Compatible MRidium 3860+ IV Infusion Pump FDA Cleared

iradimed-pump

 

IRadimed, a company out of Winter Springs, Florida, won FDA clearance for its MRidium 3860+ MRI-compatible IV infusion pump. The device has non-magnetic motor and no ferrous (containing iron) components that would be affected by a magnetic field. It’s safe to use around MRI machines up to 3.0 Tesla, which means just about any scanner found inside a hospital.

mridiumThe device can pump doses from 0.1 mL to 1,400 mL per hour, and so can be used with pediatric and adult patients that may need very different infusion rates.

Thanks to a built-in lithium battery, the device can be self-powered for up to 12 hours at 125 mL per hour.

  • World’s ‘Only’ Non–Magnetic IV Infusion Pump
  • Placement up to the 10,000 Gauss Line
  • Intuitive Smart IV Pump technology reduces field errors
  • Expandable to a second infusion channel
  • Masimo™ SpO2 Patient Monitoring
  • Large 10-Numeric Keypad – Quick Programming
  • Infusion Range – 0.1 to 1400 mL/Hr
  • Over 12–Hour Battery at 125mL/Hr
  • Adjustable KVO Rate
  • Upstream / Downstream Occlusion Detection
  • Air-in-Line Detection
  • Delivery via Syringe, Bag or Bottle

Product page: MRidium 3860+…

Via: IRadimed…

Full story

St. Jude’s EnSite Precision Cardiac Mapping System Cleared in U.S.

St. Jude’s EnSite Precision Cardiac Mapping System Cleared in U.S.

ensite

 

ensite

 

St. Jude Medical won FDA clearance for its EnSite Precision cardiac mapping system and the Advisor FL Circular Mapping Catheter, Sensor Enabled. The electrophysiology system is intended to help identify ablation targets in patients with cardiac arrhythmias, including atrial fibrillation or ventricular tachycardia. It can be used with any electrophysiology catheters, and built-in tools help reduce radiation exposure by relying less on fluoroscopy.

The EnSite Precision is based on the popular EnSite Velocity system, and now offers features such as EnSite AutoMap Module for helping to correlate the source of the electrical signals with the physical anatomy of the heart. Additionally, the same module has a so-called TurboMap capability for quickly creating a map of the heart from recorded data.

The company believes that clinicians should expect shorter mapping times and therefore faster completion of cardiac ablation procedures.

The system has been CE Marked in Europe since January of 2016.

Product pages: EnSite Precision Cardiac Mapping System…Advisor FL Circular Mapping Catheter, Sensor Enabled…

Via: St. Jude Medical…

Full story

ClearLine IV Air Bubble Clearing System Cleared in Europe

ClearLine IV Air Bubble Clearing System Cleared in Europe

clearline

 

clearline-animation

 

ClearLine IV, a device from ClearLine MD(Woburn, MA) designed to prevent air bubbles from entering the body via IV lines, has received the CE Mark approval allowing it to be marketed in Europe.

An air embolism can be extremely dangerous, potentially causing strokes, heart attacks, and respiratory failure. This can happen if an IV bag is not prepared properly or accidentally during bag placement or medication injection. These days air bubbles are typically detected manually by simply looking at the IV lines, which at times leads to missed bubbles that are allowed to pass through.

The ClearLine IV device uses ultrasound to continuously monitor the IV tube for air bubbles, automatically redirecting those into a disposable bag. It can even detect bubbles as small as 25 microliters, which may not even be recognized with today’s approaches. The device works with any pump, warmer, or IV bag set and doesn’t require any intervention once it’s enabled.

The product has already been cleared by the FDA for sale in the United States.

Product page: ClearLine IV…

Via: ClearLine MD…

Full story

Retinal Implants: Advanced Technology is giving blind people back their sight

Retinal Implants: Advanced Technology is giving blind people back their sight

tmr-160x160106

 

Retinal implants are biomedical microchips designed to provide visual perception to people who have lost vision owing to degenerative eye diseases such as retinitis pigmentosa and age-related macular degeneration. These conditions lead to slow degeneration of photoreceptor cells in the retina of human eyes, leading to gradual loss of sight. However, some of the inner retinal neurons capable of transmitting signals from photoreceptors to the brain are preserved in most cases. Electrical stimulation of these remaining retinal neurons with the help of retinal implants, which are essentially microchips containing an array of light-sensitive diodes capable of converting incident light into electrical signals, can help reintroduce some vision to patients.

The report presents a detailed overview of the present state of the global retinal implants market and its crucial elements. It presents an analysis of the major factors that will influence the growth dynamics of the market and shape its future.

Download exclusive Sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10313

The data has been gathered with the help of primary and secondary research methodologies, and narrowed down with the help of industry-leading analytical methods. A definitive account of the regulatory scenario governing market decisions has also been included in the report, along with an analysis of the expected impact of the regulatory scenario on the market.

Retinal Implants Market: Present Scenario

Retinal implants were considered a medical impossibility until a few decades ago, primarily owing to the highly complex design of the human eye. However, some retinal implants have successfully cleared clinical trials and are being regularly used in clinics in developed regions such as Europe and North America.

Retinal implants such as Alpha IMS, developed by Germany-based Retina Implant AG, and Argus II, developed by U.S.-based Second Sight Medical Products, have received approval for large-scale marketing and are being successfully implanted in patients with retinitis pigmentosa.

With the rising number of successful outcomes of retinal implants and advancement in technologies, the global retinal implants market holds immense potential in helping patients with RP and several other degenerative conditions regain their sight.

View exclusive Global strategic Business report :
http://www.transparencymarketresearch.com/retinal-implant-market.html

Increase in the geriatric population and the consequent rise in the prevalence of degenerative conditions, technological advancements, and growing disposable income in developing countries will act as major drivers of the global retinal implant market in the next few years.

Currently, retinal implants available in the market fall into two categories: epiretinal implants, which are fixed on the retina, and subretinal implants, which are fitted behind the retina. Retinal implants that can be fitted above the vascular choroid, called suprachoroidal implants, are also in clinical trials.

Retinal Implants Market: Challenges and Growth Opportunities

Biocompatibility and long-term stability of the material used for devising retinal implants are the major challenges in the global retinal implants market. These technical challenges have induced manufacturers and researchers to explore the use of new materials and combinations that will be most suitable for human eyes. This factor acts as a major restraint of the market as well as a major opportunity for medical device manufacturers and researchers.

Lack of medical reimbursement in developing and underdeveloped countries is a key issue restraining the global retinal implants market. In Germany, the Alpha IMS microchip is reimbursed by the statutory health insurance system, which insures 90% of the country’s population.

Complex surgery, difference in people’s biological response to foreign objects being placed inside their bodies, and high cost of procedures are the other major challenges faced by the global retinal implants market. Owing to the complex nature of implant surgeries, comprehensive training in the technology and technique and appropriate selection of patients is also a crucial factor governing the large-scale adoption of retinal implants. Dearth of trained professionals in several regions is limiting demand for retinal implants.

Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Full story

Exclusive: Eko Core Advanced Digital Stethoscope Now Cleared and Available in Europe

Exclusive: Eko Core Advanced Digital Stethoscope Now Cleared and Available in Europe

eko-core

 

Eko Core, the digital stethoscope from Eko Devices, a Berkeley, CA firm, is now CE Mark cleared for introduction in Europe. We reviewed the Eko Core a few months ago and discovered that it’s much more than a high-fidelity amplified stethoscope. You can store and share auscultations, as well as analyze and annotate them using a paired app, which wirelessly connects to the Eko Core. You can even listen to recordings shared by other clinicians through the Eko Core, so you can hear exactly what they heard when they conducted the exam.

eko

Everything can be stored to an electronic medical record (EMR), just like a radiologist would save patient CT scans, and these can be compared during future exams. The data can even be live-streamed for tele-medicine applications, such as allowing cardiology specialists to help to diagnose patients in remote and understaffed clinics. All the sharing and streaming is done using HIPAA-compliant software, allowing it to be used and integrated into existing clinical practices and their IT systems.

The Eko Core was approved by the a little over a year ago and CE Mark now allows it to be distributed in Europe, including UK. It has already been adopted by over 3,000 U.S. clinicians at over 400 hospitals and clinics.

Flashbacks: Review: Eko Core Digital Stethoscope…Eko Core Stethoscope with Novel Digital Capabilities FDA Cleared…

Product page: Eko Core…

Link: Eko’s announcement…

Related Posts Plugin for WordPress, Blogger...

Full story

Page 1 of 1612345...10...Last »
Copyright © 2017 Medical Technology & Gadgets Blog MedicalBuy.net. All rights reserved.
Proudly powered by WordPress. Developed by Deluxe Themes